Bioactivity:

CB 300919 is a quinazoline-based antitumor agent with high activity in the CH1 human ovarian tumor xenograft and has continuous exposure (96 h) growth inhibition (IC50: 2 nM).

CAS nr:

289715-28-2

Purity:

98%

Molecular Weight:

584,11

SMILES:

CN1CCN(CC1)CC2=NC3=C(C(N2C)=O)C=C(CN(CC#C)C4=CC=C(C=C4)C(NCC5=CC=CN=C5)=O)C(Cl)=C3

Formula:

C32H34ClN7O2

Pathway:

Others

Target:

Others